What is the appropriate treatment for a symptomatic adult male with a serum total testosterone of 384 ng/dL?

Treatment Decision for Testosterone Level of 384 ng/dL

A testosterone level of 384 ng/dL falls into a gray zone where treatment depends critically on whether the patient has clear symptoms of androgen deficiency and confirmatory repeat testing showing consistently low levels. This value sits above some treatment thresholds but below others recommended by major guidelines.

Diagnostic Confirmation Required First

Before any treatment decision, you must:

• Repeat morning fasting total testosterone measurement to confirm the low level, as single measurements are insufficient for diagnosis 1
• The diagnosis of testosterone deficiency requires both consistently low testosterone levels and clinical symptoms—not just a number 1
• Measure free or bioavailable testosterone if the patient has conditions affecting SHBG (obesity, aging, diabetes, liver disease) 1

Treatment Thresholds: The Guideline Controversy

The evidence reveals significant disagreement among expert panels on where to draw the treatment line:

Conservative threshold (Endocrine Society 2006):

• Some panelists favored treating symptomatic men only below 300 ng/dL
• Others required levels below 200 ng/dL 1
• The panel explicitly disagreed on this cutoff

More liberal threshold (ICSM 2015):

• Symptomatic men with total testosterone <350 ng/dL (12 nmol/L) should be treated 2
• A trial of therapy can even be considered in symptomatic men >350 ng/dL based on clinical presentation 2

At 384 ng/dL, your patient falls above the conservative Endocrine Society threshold but within the range where ICSM suggests treatment trials are reasonable if symptomatic.

Symptom Assessment: What Specifically to Look For

Evaluate for these specific androgen deficiency symptoms:

Sexual symptoms (strongest evidence for treatment benefit):

• Decreased libido/sexual desire
• Erectile dysfunction (after ruling out vascular, neurologic causes)
• Reduced frequency of morning erections
• Decreased ejaculate volume 1

Other symptoms (weaker evidence):

• Fatigue and decreased energy
• Depressed mood
• Loss of muscle mass and strength
• Increased body fat
• Reduced bone density or low-trauma fractures 1

Critical point: The American College of Physicians (2020) recommends against initiating testosterone for energy, vitality, physical function, or cognition, as evidence shows minimal benefit for these outcomes 3. Treatment should focus on sexual dysfunction.

My Recommendation for 384 ng/dL

If the patient has clear sexual dysfunction symptoms (low libido or erectile dysfunction):

1. Confirm with repeat morning testosterone—if still in the 300-400 ng/dL range on repeat testing
2. Consider measuring free testosterone, especially if patient is >60 years old or obese (SHBG may be elevated, masking true androgen deficiency) 4
3. Offer a trial of testosterone therapy with explicit discussion that evidence at this level is less robust than for men with unequivocally low levels (<300 ng/dL) 2
4. Set clear expectations: reassess at 12 months and discontinue if no improvement in sexual function 3

If the patient lacks sexual symptoms or only has nonspecific symptoms (fatigue, mood changes):

• Do not initiate testosterone therapy 3
• Address lifestyle factors: weight loss if obese, optimize sleep, review medications that may lower testosterone
• Investigate other causes of symptoms

Contraindications to Screen For Before Treatment

Absolutely exclude these before starting therapy:

• Prostate or breast cancer
• PSA >3-4 ng/mL without urological evaluation (check baseline PSA in men >40 years) 5, 1
• Hematocrit >50% 1
• Severe untreated sleep apnea
• Severe lower urinary tract symptoms (IPSS >19)
• Class III-IV heart failure
• Recent major cardiovascular event 1

Treatment Approach If Initiated

Formulation choice:

• Intramuscular testosterone (enanthate or cypionate) 75-100 mg weekly or 150-200 mg every 2 weeks is preferred as first-line due to significantly lower cost compared to transdermal formulations, with similar efficacy and safety 3
• Transdermal gel 5-10g daily is an alternative if patient prefers or cannot tolerate injections 1

Target testosterone level during treatment:

• Aim for mid-normal range (450-600 ng/dL) 6
• Check level at 3 months, then adjust dose 1, 5

Monitoring schedule:

• Clinical assessment at 3 months, then every 6-12 months 5
• Testosterone level at 3 months
• Hematocrit at baseline, 3 months, then annually—stop if >54% 1, 5
• PSA and digital rectal exam at baseline, 3-6 months, then per age-appropriate screening 5
• Reassess symptoms at 12 months and discontinue if no benefit 3

Common Pitfalls to Avoid

1. Don't treat based on a single testosterone measurement—always confirm with repeat testing 1
2. Don't ignore free testosterone in older men or those with obesity—up to 17-26% may have normal total testosterone but low free testosterone due to elevated SHBG 4
3. Don't continue therapy indefinitely without reassessing benefit—if sexual symptoms don't improve by 12 months, stop treatment 3
4. Don't use testosterone to treat nonspecific symptoms like fatigue alone—evidence doesn't support this 3, 7